BSEKerala Ayurveda LtdMinimalNeutral
Announced Sat, 30 May · 10:44 IST

ASCR 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.6%1-day move
₹193.25
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-7.6-9.2-12.0-7.9-12.4-10.5-1.4-6.6
Up moveDown movePending
AI summary

Kerala Ayurveda Limited has submitted its Secretarial Compliance Report for FY 2025-26 prepared by M/s. SVJS & Associates, Company Secretaries. The report identifies 8 current-year non-compliances across various SEBI regulations. Key violations include: (1) Board did not have required proportion of independent directors from April to June 2025, resulting in a fine of Rs. 5.31 lakh (waiver rejected); (2) Integrated filings signed by CFO instead of CEO/Compliance Officer due to vacancy/maternity leave; (3) Shareholding pattern for Q3 FY25 not filed on time, fine of Rs. 2,360 paid; (4) XBRL intimations for postal ballot and director cessation delayed; (5) Annual report not in searchable format; (6) Related party transaction disclosures incomplete regarding subsidiary transactions. Additionally, 18 prior-year observations remain on record, including a Rs. 5.80 lakh SEBI settlement for related party transaction violations with Ayurvedagram Heritage Wellness Centre. Management states steps are being taken to ensure future compliance.

Likely market impact

Multiple regulatory non-compliances and fines indicate weak governance systems. The Rs. 5.31 lakh penalty for board composition and SEBI settlement signal ongoing compliance issues. While most violations are procedural and management claims corrective action, repeated XBRL and disclosure delays suggest operational gaps. Shareholders should monitor whether the company achieves full compliance going forward.